Stay updated on AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page.

Latest updates to the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.5.2 was added, and revision v3.5.0 was removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. No substantive page content or functionality changes accompany this update.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision history adds v3.4.3 and removes v3.4.2.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.2. Removed the lapse-in-government-funding notice and the Revision: v3.4.1.SummaryDifference0.9%

- Check81 days agoChange DetectedThe history shows a new site-wide notice about government funding and a new revision tag (v3.4.1) in place of the deleted v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check88 days agoChange DetectedAdditions introduce a glossary display and color-coded change indicators (green for additions, red for deletions) along with a new revision label (v3.4.0) on the Record History page. Deletions remove the old No FEAR Act data note and the v3.3.4 revision text; these are UI and versioning changes rather than core study content—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page.